Ticker: GSK CUSIP: 37733W204 Class: SPONSORED ADR
Note: Option positions (PUT/CALL) are excluded.
| Period | Shares | Value ($000) | Average Close | Price Range |
|---|---|---|---|---|
| Q4 2025 | 25,130,160 | $1,232,383 | — | — |
| Q3 2025 | 25,766,950 | $1,112,102 | — | — |
| Q2 2025 | 27,726,780 | $1,064,708 | — | — |
| Q1 2025 | 25,708,020 | $995,929 | — | — |
| Q4 2024 | 25,261,660 | $854,349 | — | — |
| Q3 2024 | 14,853,755 | $607,222 | — | — |
| Q2 2024 | 14,511,390 | $558,689 | — | — |
| Q1 2024 | 12,738,370 | $546,094 | — | — |
| Q4 2023 | 12,089,370 | $448,032 | — | — |
| Q3 2023 | 12,058,770 | $437,130 | — | — |
| Q2 2023 | 11,771,770 | $419,546 | — | — |
| Q1 2023 | 9,871,510 | $351,228 | — | — |
| Q4 2022 | 3,765,920 | $132,334 | — | — |
| Q3 2022 | 441,120 | $12,982 | — | — |